Besremi 250 μg / 0,5 ml, Injektionslösung im Fertigpen

7680674880011 CH-67488 Injektionslösung im Fertigpen
Besremi 250 μg / 0,5 ml, Injektionslösung im Fertigpen
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
1
Selling units
1
Measure
Injektor(en), vorgefüllt/Pen
Galenic form
Injektionslösung im Fertigpen
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
07/07/2026
Patient information leaflet
Français
07/07/2026
Patient information leaflet
Italien
07/07/2026
Summary of Product Characteristics
Allemand
01/08/2025
Summary of Product Characteristics
Français
01/08/2025
Summary of Product Characteristics
Italien
01/08/2025

Detailed composition

Substance Quantity Type Category
ropeginterferonum alfa-2b
250.0 UG Substance Wirkstoff (Principe actif)
natrii chloridum
- Substance HNIDK
natrii acetas
- Substance HNIDK
acidum aceticum glaciale
- Substance HNIDK
alcohol benzylicus
5.0 MG Substance HBESI
polysorbatum 80
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
1.8 MG Substance HBESI

Reimbursement information

Public price
CHF 1653.80
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/12/2021

Authorization holder

OrPha Swiss GmbH

8700 Küsnacht ZH

Authorization information

Swissmedic authorization number
67488
Drug name
Besremi, Injektionslösung im Fertigpen
Galenic form
INLFP
ATC Code
L03AB15
Authorization status
Z
Dispensing category
A
First authorization
01/07/2020
Authorization expiration date
31/12/9999
IT Number
07.16.1.
Domain
Human medicine
Field of application
Polycythaemia vera

Package details

Description (FR)
BESREMI sol inj 250 µg/0.5 ml 1 stylo pré 0.5 ml
Description (DE)
BESREMI Inj Lös 250 µg/0.5 ml 1 Fertpen 0.5 ml
Market launch
01/07/2020
Narcotic (BTM)
No

Other package sizes (1)

None
1 INJ
GTIN: None
Not in V1
Buy us a coffee Explore the data